I will reflect very carefully on the points that my hon. Friend has made. It is important to recognise, however, that we have an issue with one particular scientific adviser, and that in no way reflects on any of the other many advisers that we have from the scientific community. I would not like this to be classified as a more general problem than it actually is.
Advisory Council on the Misuse of Drugs
Proceeding contribution from
Alan Johnson
(Labour)
in the House of Commons on Monday, 2 November 2009.
It occurred during Urgent question on Advisory Council on the Misuse of Drugs.
Type
Proceeding contribution
Reference
498 c581 
Session
2008-09
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2023-11-25 19:52:14 +0000
URI
http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1459075/answer
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1459075/answer
In Solr
https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1459075/answer